Jaffee EM - Search Results

1

Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade.

Berry S, Giraldo NA, Green BF, Cottrell TR, Stein JE, Engle EL, Xu H, Ogurtsova A, Roberts C, Wang D, Nguyen P, Zhu Q, Soto-Diaz S, Loyola J, Sander IB, Wong PF, Jessel S, Doyle J, Signer D, Wilton R, Roskes JS, Eminizer M, Park S, Sunshine JC, Jaffee EM, Baras A, De Marzo AM, Topalian SL, Kluger H, Cope L, Lipson EJ, Danilova L, Anders RA, Rimm DL, Pardoll DM, Szalay AS, Taube JM. Berry S, et al. Among authors: jaffee em. Science. 2021 Jun 11;372(6547):eaba2609. doi: 10.1126/science.aba2609. Science. 2021. PMID: 34112666 Free PMC article.

2

Herpes simplex-1 virus thymidine kinase gene is unable to completely eliminate live, nonimmunogenic tumor cell vaccines.

Golumbek PT, Hamzeh FM, Jaffee EM, Levitsky H, Lietman PS, Pardoll DM. Golumbek PT, et al. Among authors: jaffee em. J Immunother (1991). 1992 Nov;12(4):224-30. doi: 10.1097/00002371-199211000-00002. J Immunother (1991). 1992. PMID: 1335754

3

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens.

Huang AY, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H. Huang AY, et al. Science. 1994 May 13;264(5161):961-5. doi: 10.1126/science.7513904. Science. 1994. PMID: 7513904

4

A reassessment of the role of B7-1 expression in tumor rejection.

Wu TC, Huang AY, Jaffee EM, Levitsky HI, Pardoll DM. Wu TC, et al. Among authors: jaffee em. J Exp Med. 1995 Nov 1;182(5):1415-21. doi: 10.1084/jem.182.5.1415. J Exp Med. 1995. PMID: 7595212 Free PMC article.

5

Simplified high-sensitivity sequencing of a major histocompatibility complex class I-associated immunoreactive peptide using matrix-assisted laser desorption/ionization mass spectrometry.

Woods AS, Huang AY, Cotter RJ, Pasternack GR, Pardoll DM, Jaffee EM. Woods AS, et al. Among authors: jaffee em. Anal Biochem. 1995 Mar 20;226(1):15-25. doi: 10.1006/abio.1995.1185. Anal Biochem. 1995. PMID: 7785766 Free article.

6

Bone marrow-derived cells present MHC class I-restricted tumour antigens in priming of antitumour immune responses.

Huang AY, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H. Huang AY, et al. Ciba Found Symp. 1994;187:229-40; discussion 240-4. doi: 10.1002/9780470514672.ch15. Ciba Found Symp. 1994. PMID: 7796673 Review.

7

Gene therapy: its potential applications in the treatment of renal-cell carcinoma.

Jaffee EM, Pardoll DM. Jaffee EM, et al. Semin Oncol. 1995 Feb;22(1):81-91. Semin Oncol. 1995. PMID: 7855623 Review. No abstract available.

8

Controlled release, biodegradable cytokine depots: a new approach in cancer vaccine design.

Golumbek PT, Azhari R, Jaffee EM, Levitsky HI, Lazenby A, Leong K, Pardoll DM. Golumbek PT, et al. Among authors: jaffee em. Cancer Res. 1993 Dec 15;53(24):5841-4. Cancer Res. 1993. PMID: 8261390

9

High efficiency gene transfer into primary human tumor explants without cell selection.

Jaffee EM, Dranoff G, Cohen LK, Hauda KM, Clift S, Marshall FF, Mulligan RC, Pardoll DM. Jaffee EM, et al. Cancer Res. 1993 May 15;53(10 Suppl):2221-6. Cancer Res. 1993. PMID: 8485707

10

Enhanced immune priming with spatial distribution of paracrine cytokine vaccines.

Jaffee EM, Thomas MC, Huang AY, Hauda KM, Levitsky HI, Pardoll DM. Jaffee EM, et al. J Immunother Emphasis Tumor Immunol. 1996 May;19(3):176-83. doi: 10.1097/00002371-199605000-00002. J Immunother Emphasis Tumor Immunol. 1996. PMID: 8811492

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

346 results

Search Page

Filters